Drug development in IBD: from novel target identification to early clinical trials

被引：41
作者：
Danese, Silvio [1 ]
Fiocchi, Claudio [2 ,3 ]
Panes, Julian [4 ]
机构：
[1] Humanitas Univ, Humanitas Res Hosp, Dept Gastroenterol, IBD Ctr, Milan, Italy
[2] Inst Digest Dis, Dept Gastroenterol & Hepatol, Cleveland, OH USA
[3] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[4] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, CIBERehd, Barcelona, Spain
来源：
GUT | 2016年 / 65卷 / 08期
关键词：
INFLAMMATORY-BOWEL-DISEASE; RECOMBINANT HUMAN INTERLEUKIN-10; ACTIVE CROHNS-DISEASE; TUMOR-NECROSIS-FACTOR; ANIMAL-MODELS; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; MAINTENANCE INFLIXIMAB; CYTOKINE PRODUCTION; RANDOMIZED-TRIAL;
D O I：
10.1136/gutjnl-2016-311717
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1233 / 1239
页数：7
相关论文
共 63 条
[21]   EXPERIMENTAL-MODELS OF INFLAMMATORY BOWEL-DISEASE [J].
ELSON, CO ;
SARTOR, RB ;
TENNYSON, GS ;
RIDDELL, RH .
GASTROENTEROLOGY, 1995, 109 (04) :1344-1367
[22]   Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease [J].
Fedorak, RN ;
Gangl, A ;
Elson, CO ;
Rutgeerts, P ;
Schreiber, S ;
Wild, G ;
Hanauer, SB ;
Kilian, A ;
Cohard, M ;
LeBeaut, A ;
Feagan, B .
GASTROENTEROLOGY, 2000, 119 (06) :1473-1482
[23]   Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions [J].
Fiocchi, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1997, 273 (04) :G769-G775
[24]   From immune activation to gut tissue injury: The pieces of the puzzle are coming together [J].
Fiocchi, C .
GASTROENTEROLOGY, 1999, 117 (05) :1238-1241
[25]   Integrating Omics: The Future of IBD? [J].
Fiocchi, Claudio .
DIGESTIVE DISEASES, 2014, 32 :96-102
[26]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[27]   Intestinal Microbiota in Animal Models of Inflammatory Diseases [J].
Hoermannsperger, G. ;
Schaubeck, M. ;
Haller, D. .
ILAR JOURNAL, 2015, 56 (02) :179-191
[28]   Multi-omics analysis of inflammatory bowel disease [J].
Huang, Hu ;
Vangay, Pajau ;
McKinlay, Christopher E. ;
Knights, Dan .
IMMUNOLOGY LETTERS, 2014, 162 (02) :62-68
[29]   Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial [J].
Hueber, Wolfgang ;
Sands, Bruce E. ;
Lewitzky, Steve ;
Vandemeulebroecke, Marc ;
Reinisch, Walter ;
Higgins, Peter D. R. ;
Wehkamp, Jan ;
Feagan, Brian G. ;
Yao, Michael D. ;
Karczewski, Marek ;
Karczewski, Jacek ;
Pezous, Nicole ;
Bek, Stephan ;
Bruin, Gerard ;
Mellgard, Bjoern ;
Berger, Claudia ;
Londei, Marco ;
Bertolino, Arthur P. ;
Tougas, Gervais ;
Travis, Simon P. L. .
GUT, 2012, 61 (12) :1693-1700
[30]   Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis [J].
Hueber, Wolfgang ;
Patel, Dhavalkumar D. ;
Dryja, Thaddeus ;
Wright, Andrew M. ;
Koroleva, Irina ;
Bruin, Gerard ;
Antoni, Christian ;
Draelos, Zoe ;
Gold, Michael H. ;
Durez, Patrick ;
Tak, Paul P. ;
Gomez-Reino, Juan J. ;
Foster, C. Stephen ;
Kim, Rosa Y. ;
Samson, C. Michael ;
Falk, Naomi S. ;
Chu, David S. ;
Callanan, David ;
Quan Dong Nguyen ;
Rose, Kristine ;
Haider, Asifa ;
Di Padova, Franco .
SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (52)
1234567